Improved Treatments for Brain Cancers Highlighted at Annual Society of Neuro-Oncology (SNO) Meeting

Improved Treatments for Brain Cancers Highlighted at Annual Society of Neuro-Oncology (SNO) Meeting

ID: 98677

(firmenpresse) - LOS ANGELES, CA -- (Marketwire) -- 12/20/11 -- Among the few advances in improved treatments for brain cancers presented to the 1,400 Neuro-oncologists and other cancer researchers who met recently in Anaheim for the Annual Society of Neuro-oncology (SNO) meeting were Celldex's CDX-110 and Immunocellular Therapeutics' (OTCBB: IMUC) ICT-107.

Some summaries on the conference which may provide insights into new developments in new treatments for brain cancers are provided in a newly published Expert Briefing. Some of the most promising approaches were in the area of immunotherapy/vaccines, and were featured during several standing room only sessions. Investors can now read about some of the insights into these new developments.

The full Expert Briefing report, including information about the combination of vaccines and immune modulators, is available now at:



In addition, investors interested in accessing BioMedReports' new complete database of clinical trials and upcoming FDA and world-wide regulatory decisions which can be used to make more profitable trades during these volatile markets can go to:



News developments and live healthcare sector updates are available constantly via twitter at:

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets. Full disclosures and information about these stocks and news are available at BioMedReports.Com





Media Contacts Only:
Mary Davila
Assistant Editor
BioMedReports.Com
e-mail:
Tel: +1 323 472 4480
Fax: +1 888 210 3556



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Newbridge signs Share Purchase Agreement for Proposed Transaction Introducing The Bar Method Salt Lake City
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 20.12.2011 - 13:46 Uhr
Sprache: Deutsch
News-ID 98677
Anzahl Zeichen: 0

contact information:
Town:

LOS ANGELES, CA



Kategorie:

Venture Capital



Diese Pressemitteilung wurde bisher 184 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Improved Treatments for Brain Cancers Highlighted at Annual Society of Neuro-Oncology (SNO) Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von

BioMedReports (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Q&A With Coronado Biosciences CEO Harlan Weisman, M.D. ...

LOS ANGELES, CA -- (Marketwired) -- 07/23/13 -- It has been over a year since Coronado Biosciences, and the company, so we thought it time for an updated Q&A on this biopharmaceutical company that continues to be one of biotech's most talk ...

Alle Meldungen von BioMedReports



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z